Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Clinico-pathological characteristics of the patients in the whole series, and according to type of chemotherapy

From: Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer

Characteristics No. of patients Platinum-containing chemotherapy No. (%) Platinum/paclitaxel containing chemotherapy No. (%)
All cases 68 39 29
Age (yrs)    
   <60 43 22 (51.2) 21 (48.8)
   ≥60 25 17 (68.0) 8 (32.0)
FIGO Stage    
   IIIC 50 31 (62.0) 19 (38.0)
   IV 18 8 (44.4) 10 (55.6)
Cytoreduction    
RT <1 cm 18 12 (66.7) 6 (33.3)
RT ≥1 cm 50 27 (54.0) 7 (14.0)
Ascites    
   No 16 8 (50.0) 8 (50.0)
   Yes 52 29 (55.8) 23 (44.2)
Histotype    
   Serous 54 32 (59.2) 22 (40.7)
   Endometrioid 8 5 (62.5) 3 (37.5)
   Undifferentiated 6 2 (33.3) 4 (66.7)
   Other 3 2 (66.7) 1 (33.3)
Grade    
   G1-2 10 8 (80.0) 2 (20.0)
   G3 53 30 (56.6) 23 (43.4)
   n.a. 5   
COX-2    
Negative 36 19 (52.8) 17 (47.2)
Positive 32 20 (62.5) 12 (37.5)